Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue
- Source
- The Economic Times - Industry
- Source link
- https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gland-pharma-inks-strategic-cdmo-deal-with-global-pharma-firm-eyes-90-100-million-annual-revenue/articleshow/133062684.cms
- Published
- 2026-08-09 05:42:46
- Discovered by ProcIntel
- 2026-08-09 05:48:46
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Gland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer, manufacturing and supply of sterile injectable products. The agreement covers 55 SKUs across three sites, with annualised revenue potential of $90-100 million upon commercialisation. Revenue generation is expected to begin in 2029.
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-08-09 05:48:47
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.